Diagnosis and therapy of occult primary tumors with lymph-node metastases in the head and neck region;Diagnostik und Therapie des okkulten Primartumors mit Lymphknotenmetastasen im Kopf-, Halsbereich

HNO

Volumn 45, Issue 7, 1997, Pages 573-583

  Jungehulsing M ^a   Eckel, H E ^a   Staar, S ^a   Ebeling, O ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Universitat zu Koln ^*

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; HUMAN; LYMPH NODE METASTASIS; NECK DISSECTION; PRACTICE GUIDELINE; REVIEW;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; NECK DISSECTION; NEOPLASMS, UNKNOWN PRIMARY; PROGNOSIS; RADIOTHERAPY, ADJUVANT;

EID: 0030755951     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (108)

1. Abbruzzese JL, Abbruzzese MC, Hess KR, et al. (1994) Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 12 1272-1280
2. Abbruzzese JL, Raber MN, Frost P (1988) An effective strategy for the evaluation of unknown primary tumors. Cancer Bull 41:157-161
3. Abbruzzese JL, Abbruzzese-MC, Lenzi-R, Hess-KR, Raber-MN (1995) Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol 13:2094-2103
4. Abrams HL, Spiro R, Goldstein N (1950) Metastases in carcinoma. Analysis of 1000 autopsied cases. Cancer 3:74-85
5. Altman E, Cadman E (1986) An analysis of 1539 patients with cancer of unknown primary site. Cancer 57:120-124
6. Altmannsberger-M, Droese-M, Osborn-M, Weber-K (1984) Immunzytologische Klassifizierung von Metastasen bei unbekanntem Primärtumor. Pathologe 5:269-274
7. Bailet JW, Abemayor E, Jabour BA, Hawkins RA, HoC, Ward PH (1992) Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 102:281-288
8. Bataini JP, Roriguez J, Jaulery C, Brugere J, Ghoseim NA (1987) Treatment of metastatic neck nodes secondary to an occult epidermoid carcinoma of the head and neck. Laryngoskope 97:1080-1084
9. Bossman FT, Giard RWM, Kruseman ACN, et al. (1980) Human chorionic gonadotropin and alpha-fetoprotein in testicular germ cell tumours: a retrospective immunohistochemical study. Kistopathology 4:673-684
10. Brewin T (1981) The cancer patient - too many scans and X-rays? Lancet 1:1098-1099
11. Carter RL, Bliss JM, Soo KC, O'Brien-CJ (1987) Radical neck dissection for squamous carcinomas, pathological findings and their clinical implications with particular reference to transcapsular spread, Int J Radiat Biol Oncol Phys 13:825-832
12. Coker DD, Casterline PF, Chambers RG, Jaques-DA (1977) Metastases to the lymph nodes of the head and neck from an unknown primary site. Am J Surg 134:517-522
13. Comess MS, Beahrs OH, Dockerty MB (1957) Cervical Metastasis from occult carcinoma. Surg Gynecol Obstet 104:607-617
14. Compagne J, Hyams VJ, Safavian M (1976) Does branchiogenic carcinoma really exist? Arch Pathol Lab Med 100:311-314
15. Daugaard D (1994) Unknown primary tumours. Cancer Treatment Reviews 20:119-147
16. Davidson BJ, Spiro RH, Patel S, Shah JP (1994) Cervical metastases of occult origin: the impact of combined modality therapy. Am J Surg 168:395
17. de Braud F, Heilbrun LK, Ahmed K, et al. (1989) Metastatic squamous cell carcinoma of an unknown primary localised to the neck. Advantages of an aggressive treatment. Cancer 64:510-515
18. de Campos ES, Menasce LP, Radford J, Harris M, Thatcher N (1994) Metastatic carcinoma of uncertain primary site: a retrospective review of 57 patients treated with vincristine, doxorubicin, cyclophosphamide (VAC) or VAC alternating with cisplatin and etoposide (VAC/PE). Cancer 73:470-475
19. Delank KW, Freytag G, Stoll W (1992) Klinische Relevanz der malignen lateralen Halszysten.Laryngorhinootologie 71:611-617
20. Didolkar MS, Fanous N, Elias EG, Moore RH (1977) Metastatic carcinomas from occult primary tumors. A study of 254 patients. Ann Surg 186:625
21. Dohnert-G (1971) Lymphoepithelioma Schmincke-Regaud. Virchows Arch Pathol Anat Physiol Klin Med 352:279-284
22. Duda RB, Zimmer AM, Rosen ST(1990) Radioimmune localization of occult carcinoma. Arch Surg 125:866-870
23. Dunst-J, Sauer-R, Weidenbecher-M (1988) Halslymphknotenmetastasen bei unbekanntem Primärtumor. Strahlenther Onkol 164:129-135
24. Fitzpatrick PJ, Kotalik JF (1974) Cervical metastases from an unknown primary tumor. Radiology 110:659-663
25. Fletcher JA, Kozakewich TP, Hoffer FA (1991) Diagnostic relevance of clonal cytogenetic aberrations in malignant soft tissue tumors. N Engl J Med 324:436-441
26. France CJ, Lucas R (1963) The management and prognosis of metastatic neoplasms of the neck with an unknown primary. Am J Surg 106:835
27. Frost P (1991) Unknown primary tumors: an example of accelerated (type2) tumor progression. In Sudilovski, O., Ed. Boundaries between promotion and progression during carcinogenesis. New York:, Plenum Press, pp 233-241
28. Gaber AO, Rice P, Eaton C, Pietrafitta JJ, Spatz E, Deckers PJ (1983) Metastatic malignant disease of unknown origin. Am J Surg 145 493-497
29. Gatter KC (1992) Morphology of Neoplasms. In: McGee JO, Isaacson PG, Wright NA (eds) Oxford Textbook of Pathology, vol. 1 New York, Oxford University Press, pp577-585
30. Gluckman JL, Robbins KT, Fried MP (1990) Cervical metastatic squamous carcinoma of unknown or occult primary source. Head Neck 12:440-443
31. Glynne Jones RGT, Anand A, Young TE, Berry RJ (1990) Metastatic carcinoma in the cervical lymph nodes from an occult primary: a conservative approach to the role of radiotherapy. Int J Radiat Oncol 18:289-294
32. Gorich J, Beyer-Enke SA, Muller M, et al.(1988) Die Wertigkeit der Computertomographie bei der Suche nach unbekanntem Primärtumor. ROFO-Fortschr Geb Rontgenstr Nuklearmed 149-277-279
33. Grignon-DJ, Hammond-EH (1995) College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors. Report of the Prostate Cancer Working Group. Arch Pathol Lab Med 119:1122-1126
34. Hainsworth JD, Einhorn LH, Williams SD, Stewart M, Greco FA (1982) Advanced gonadal germ cell tumors: successfull treatment with combination chemotherapy. Proc Am Soc Clin Oncol 1:C-413
35. Hainsworth JD, Greco A (1983) Testicular germ cell neoplasms. Am J Med 75 817-832
36. Hainsworth JD, Wright EP, Johnson DH, Davis BW, Greco FA (1991) Poorly differentiated carcinoma of unknown primary site: clinical usefulness of immunoperoxidase staining. J Clin Oncol 9:1931-1938
37. Hamilton CS, Langlands AO (1987) Adenocarcinoma of unknown primary site: a clinical and cost benefit analysis, Int J Radiat Oncol Biol Phys 13: 1497-1503
38. Heinritz-H, Marienhagen-J, Wolf-F, et al. (1992) Szintigraphische Darstellung von Kopf-Hals-Karzinomen mit 99mTechnetium (v) Dimercaptosuccinic acid. Eine prospektive klinische Studie HNO 40:437-441
39. Jaspersen D (1992) Das CUP-Syndrom-Malignomerkrankung bei unbekanntem Primärtumor. Folge 1: Diagnostisches Prozedere. Fortschr Med 110:519-520
40. Jesse RH, Neff LE (1966) Metastatic carcinoma in cervical nodes with an unknown primary lesion. Am J Surg 112:547-553
41. Johnson JT, Barnes EL, Myers EN, et al. (1981) The extracapsular spread of tumors in cervical node metastasis. Arch Otolaryngol 107:725-729
42. Jones AS, Phillips DE, Cook JA, Field JK, Gati I (1993) Non-squamous malignancy in lymph nodes: the occult primary. Clin Otolaryngol 18:311-316
43. Jose B, Bosch A, Caldwell WL, Frias Z (1979) Metastases to neck from unknown primary tumor. Acta Radiol Oncol 18:161-170
44. Jungehulsing R M, Scheidhauer K (1994) FDG-PET im Vergleich mit CT, MRT, und Sonographie zum Staging von Kopf-, Hals-Plattenepithel-karzinomen. Eur Arch Otol Rhinol Laryngol Suppi 11: 171-172
45. Jungehülsing M, Scheidhauer K, Damm M, Schneider D (1995) 18-FDG-PET bei Patienten mit Tumoren unbekannter Primärlokalisation. Mitteilungen der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Halschirurgie, 20/1, Nr.324
46. Kambhu SA, Kelsen DP, Fiore J, et al. (1990) Metastatic adenocarcinomas of unknown primary site. Am J Clin Oncol 13:55-60
47. Kirsten F, Chi C, Leeary JA, et al. (1987) Metastatic adeno or undifferenciated carcinoma from an unknown primary site - natural histroy and guidelines for identification on treatable subsets. Quart J Med 62:143
48. Klee GG, Go VLW (1982) Laboratory report. Serum tumor markers. Mayo Clin Proc 57:129-132
49. Knobber D, Lobeck H, Steinkamp HJ (1995) Gibt es die malignisierte laterale Halszyste doch? HNO 43:104-10
50. Knothe J, Fritsche F (1980) Zur Halslymphknotenmetastasierung bei un-bekanntem Primärtumor. Laryngol Rhinol Otol 59:221-226
51. Krementz ET, Cerise EJ, Foster DS, Morgan LR (1979) Metastases of undetermined source. Curr Probl Cancer 4:4-37
52. Kruger R, de Leon F, Maihoff J (1992) Der Wert der Immunhistochemie in der histologischen Routinediagnostik von Metastasen unbekannter Primärtumoren. Pathologe 13:65-72
53. Kurtin PJ, Pinkus GS (1985) Leukocyte common antigen - a diagnostic discriminant between hematopoietic and nonhematopoietic neoplasms in paraffin sections using monoclonal antibodies. Hum Pathol 16:353-365
54. Lefebvre JL, Coche-Dequeant B, Ton Van J, Buisset E, Adenis A (1990) Cervical lymph nodes from an unknown primary tumor in 190 patients. Am J Surg 160.443-446
55. Leipzig B, Winter ML, Hokanson JA (1981) Cervical nodal metastases of unknown origin. Laryngoscope. 91.593-598
56. Leonard RJ, Nystrom JS (1993) Diagnostic evaluation of patients with carcinoma of unknwown primary tumor site. Sem Oncol 20:244-250
57. Levine PH, Connelly RR (1985) Epidemiology of nasopharyngeal cancer. In: Wiltes RE (Ed) Head and Neck Cancer. Wiley, Chichester, Ss. 13-36
58. Lote K (1989) Metastatic cancer from unknown primary site. In: Veronesi U, Arnesjo B, Burn I, Denis L, Mazzeo F (eds) Surgical Oncology. A European Handbook. Springer, Berlin Heidelberg New York, pp 976-983
59. Mackay B, Ordonez NG(1986) The role of the pathologist in the evaluation of poorly differentiated tumors and metastatic tumors of unknown origin. In: Fer MF, Greco FA, Oldham RK (Eds) Poorly Differentiated Neoplasms and Tumors of Unknown Origin. Grune & Stratton, Orlando FL, pp 3-73
60. Marcial - Vega VA, Cardenes H, Perez CA, Devineni VR, Simpson JR, Fredrickson JM, Sessions DG, Spector GG, Thawley-SE(1990) Cervical metastases from unknown primaries, radiotherapeutic management and appearance of subsequent primaries, Int J Radiat Oncol Biol Phys 19:919-928
61. Maulard C, Housset M, Brunei P, Huart J, Ucla L, Rozec C, Delanian S, Baillet F (1992) Postoperative rediation therapy for cervical lymph node metastases from an occult squamous cell carcinoma. Laryngoscope 102:184
62. McCunnif A, Raben M (1986) Metastatic carcinoma of the neck from an unknown primary, Int J Radiat Oncol Biol Phys 12:1849-1852
63. McMillan JH, Levine E, Stephens RH (1982) Computed tomography in the evaluation of metastatic adenocarcinoma from an unknown primary site. Radiology 143:143-146
64. Medina JE (1989) A rational classification of neck dissections. Otolaryngol Head Neck Surg 100:169-76
65. Moertel CG, Reitermeier RJ, Schutt AJ, Hahn RG (1972) Treatment of the patient with adenocarcinoma of unknown origin. Cancer 30:1469-1472
66. Mohit-Tabatabai MA, Dasmahapatra KS, Rush EF, Ohanian M (1986) Management of squamous cell carcinoma of unknown origin in cervical lymph nodes. Am J Surg 52.152-154
67. Motzer RJ, Rodriguez E, Reuter VE, Bosl GJ, Mazumdar M, Chaganti RS (1995) Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site. J Clin Oncol 13:274-282
68. Muir C (1995) Cancer of unknown primary site. Cancer 75, 353-356
69. Neel HB, Pearson GR, Weiland LH, Taylor WF, Goepfert HH (1981) Immunologic detection of occult primary cancer of the head and neck. Otolaryngol Head Neck Surg 89:230-234
70. Neilan BA (1983) Adenocarcinoma of unknown origin. CA 33:237-241
71. Nissenblatt MR (1981) The CUP syndrome (Carcinoma of unknown primary) Cancer Treat Rev 8:211-224
72. Nordstrom DG, Jefik HH, Latourette HB (1979) Cervical lymph node metastases from an unknown primary Int J Radiat Oncol Biol Phys 5:73-76
73. Nystrom SJ, Weiner JM, Wolf RM, Bateman JR, Viola MV (1979) Identifying the primary site in metastatic cancer of unknown origin. Inadequacy of roentgenographic procedures. JAMA 241:381-383
74. Osteen RT, Kopf G, Wilson RE (1978) In pursuit of the unknown primary. Am J Surg 135:494-498
75. Panza N, Lombardi G, Rosa M, Pacilio G, Lapenta L, Salvatore M (1987) High serum thyroglobulin levels, diagnostic indicators in patients from unknown primary sites. Cancer 60:2233-2236
76. Pearson GR, Weiland LH, Neel HB, Taylor W, Earle J, mulroney SE, Goepfert H, Lanier A, Talvot ML, Pilch B, Goodman M, Huang A, Levine PH, Hyans V, Moran E, Henle G, Henle W (1983) Application of Epstein- Barr virus serology to the diagnosis of North American nasopharyngeal carcinoma. Cancer 51:260-268
77. Pinkus GS, Kurtin PJ (1985) Epethelial membrane antigen-a diagnostic discriminant in surgical pathology: Immunohistochemical profile in epithelial, mesenchymal, and hematopoietic neoplasms using paraffin sections and monoclonal antibodies. Hum Pathol 16:929-940
78. Scanlon EF (1985) The process of metastasis. Cancer 55-1163-1166
79. Schabel FM (1975) Concepts for systemic treatment of micrometastases. Cancer 35 15-24
80. Schapira DV, Jarrett AR (1995) The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma. Arch Intern Med 155:2050-2054
81. Schicha H (1990) Kompendium der Nuklearmedizin. Schattauer, Stuttgart New York
82. Schipper JH, Schrader M, Arweiler O, Muller S, Sciuk J (1996) Die Positrone-nemissionstomographie zur Primärtumorsuche bei Halslymphkno-tenmetastasen mit unbekanntem Primärtumor. HNO 44:254-257
83. Schultz-Coulon-HJ, Peter-HH (1984) Melanommetastasen im Halsbereich bei unbekanntem Primärtumor. Laryngol-Rhinol-Otol 63:17-20
84. Smith PE, Krementz ET, Chapman W (1967) Metastatic cancer without a detectable primary site. Am J Surg 113:633-637
85. Snee MP, Vyramuthu N (1985) Metastatic carcinoma from unknown primary site: the experience of a large oncology centre. Br J Radiol 58: 1091-1095
86. Spiessl B, Hermanek O, Scheibe G, Wagner R (1985) TNM-Atlas.Illustrierter Leitfaden zur TNM/pTNM-Klassifikation maligner Tumoren. Springer, Berlin Heidelberg New York
87. Spiro RH, DeRose G, Strong EW (1983) Cervical node metastases of occult origin. Am J Surg 146:441-446
88. Steinkamp-HJ, Knobber-D, Zwicker-C, Felix-R (1993) Halslymphknotenmetastasen bei unbekanntem Primärtumor: Gibt es eine bildgebende Differentialdiagnostik? Laryngorhinootologie 72:78-85
89. Stewart JF, Tattersall MNH, Woods RL, Fox RM, (1979) Unknown primary adenocarcinoma: incidence of o verinvestigation and natural history. Br Med J 1:1530-1533
90. Strasnick B, Moore DM, Abemayer E, Juillard G, Fu YS (1990) Occult primary tumors. The management of isolated submandibular lymph node metastases. Arch Otolaryngol Head Neck Surg. 116:173-176
91. Subramanian R, Chilla R (1995) Halsymphknotenmetastasen bei unbekanntem Primartumor. Verlaufsbeobachtung an 58 Patienten. HNO 43:299-303
92. Sugarbaker EV (1980) Patterns of metastasis in human malignancies. In: Marchalonis JJ, Hanna MG, Fidler IJ (Ed.) Cancer Biology reviews, Vol. 2. Dekker, New York
93. Talmadge JE, Fidler IJ (1982) Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous m urine tumors. JNCI 69 975-980
94. Van den Brekel MPM, Castelijns JA, Steel H, Golden RP, Meyer, Snow G (1993) Modern imaging techniques and ultrasound - guided aspiration cytology for the assessment of neck node metastasis. A prospective comparative study. Eur Arch Otorhinolaryngol 250:11-17
95. van der Gaast A, Verweij J, Planting AS, Hop WC Stoter G. (1995) Simple prognostic model to predict survival in patients with undifferntiated carcinoma of unknown primary site. J Clin Oncol 13:1720-1725
96. Vannetzel JM, Dray M, Murthy AK (1990) Proc Am Soc Clin Oncol 9:660
97. Vikram B (1980) Changing patterns of failure in advanced head and neck cancer. Arch Otolaryngol 110:564-565
98. Vikram G, Strong EW, Shah JP, Spiro R (1984) Failure at the primary site following multimodality treatment in advanced head and neck cancer. Head Neck Surg 6:720-723
99. Volkmann von R (1882) Das tiefe branchiogene Halscarcinom. Zentralbl Chir 9.49-51
100. von-Heyden-HW, Hansen-D, Kaboth-U, Nagel-GA, Hoffmann-H, Schneider-B (1984) Metastasierendes Adenokarzinom bei unbekanntem Primartumor. Dtsch Med Wochenschr 109 15-19
101. Wang RC, Goepfert H, Barber AE, Wolf P (1990) Unknown primary squamous cell carcinoma metastatic to the neck. Arch Otolaryngol Head Neck Surg 116:1388-1393
102. Weir L, Keane T, Cummings B, Goodman P, O'Sullivan B, Payne D, Warde P (1995) Radiation treatment of cervical lymph node metastases from an unknown primary: an analysis of outcome by treatment volume and other prognostic factors. Radiother Oncol 35:206-211
103. Weiss L, Hadock K, Pickren JW, Lane WW (1980) Organ vascularity and metastatic frequency. Am J Pathol 101:101-114
104. Wilson CBJH (1992) Pet scanning in oncology. Eur J Cancer 28:508-510
105. Woods RL, Fox RM, Tattersall MHN, Levo JA, Brodie GN (1980) Metastatic adenocarcinomas of unknown primary site. N Eng J Med 303:87-89
106. Yam LT (1974) Clinical significance of the human acid phosphatases. Am J Med 56.604-615
107. Yang ZY, Hu YH, Yan JH, Cai WM, Qin DX, Xu GZ, Wu XL (1983) Lymph node metastases in the neck from an unknown primary, report on 113 patients. Acta Radiol Oncol 22:17-22
108. zur Hausen H, Schulte-Holthausen H, Klein G (1970) EBV DNA in biopsies of Burkitt tumors and anaplastic carcinomas of the nasopharynx. Nature 228:1056-1058